Hidetaka Yamada

7PUBLICATIONS
25CO-AUTHORS
Craniofacial biologyMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersCellular immunology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Feb 24, 2026
Ameloblastoma Displays Primary Cilia Maintenance and CEP164 Overexpression.

R Miyazaki, H Kawasaki, H Kato

|Apr 02, 2024
Correction: The spectrum of TP53 mutations in Rwandan patients with gastric cancer.

Augustin Nzitakera, Jean Bosco Surwumwe, Ella Larissa Ndoricyimpaye

|Mar 08, 2024
The spectrum of TP53 mutations in Rwandan patients with gastric cancer.

Augustin Nzitakera, Jean Bosco Surwumwe, Ella Larissa Ndoricyimpaye

|Nov 24, 2023
High Expression of Fas-Associated Factor 1 Indicates a Poor Prognosis in Non-Small-Cell Lung Cancer.

De Hu, Hidetaka Yamada, Katsuhiro Yoshimura

|Jun 30, 2023
TP53 mutations in Romanian patients with colorectal cancer.

Felix Manirakiza, Hidetaka Yamada, Yuji Iwashita

Pageof 2